Surgical treatment of salivary malignant tumors.

Davide Lombardi, Marc McGurk, Vincent Vander Poorten, Marco Guzzo, Remo Accorona, Vittorio Rampinelli, Piero Nicolai

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Salivary gland malignant tumors (SGMT) are of key interest for head and neck surgeons since surgery with adjuvant radiotherapy is considered the treatment of choice in most of the cases. Some factors, namely rarity, high histologic heterogeneity, and possible occurrence in all the head and neck subsites, contribute to make this topic very controversial; some unclear aspects pertain surgical treatment. When dealing with major salivary gland malignant tumors (MaSGMT), the most debated issues remain the extent of surgery and management of facial nerve. In minor salivary gland malignant tumors (MiSGMT), conversely, surgical planning is influenced by the specific pattern of growth of the different neoplasms as well as the site of origin of the lesion. Finally, two additional issues, the treatment of the neck (therapeutic or elective) and reconstructive strategy after ablative surgery, are of pivotal importance in management of both MaSGMT and MiSGMT. In this review, we discuss the most relevant and controversial issues concerning surgery of SGMT.
Original languageUndefined/Unknown
Pages (from-to)102-113
Number of pages12
JournalOral Oncology
Volume65
DOIs
Publication statusPublished - Feb 1 2017

Keywords

  • Malignant tumor, Minor salivary gland, Neck, Parotid, Sublingual gland, Submandibular gland, Surgery

Cite this

Lombardi, D., McGurk, M., Vander Poorten, V., Guzzo, M., Accorona, R., Rampinelli, V., & Nicolai, P. (2017). Surgical treatment of salivary malignant tumors. Oral Oncology, 65, 102-113. https://doi.org/10.1016/j.oraloncology.2016.12.007

Surgical treatment of salivary malignant tumors. / Lombardi, Davide; McGurk, Marc; Vander Poorten, Vincent; Guzzo, Marco; Accorona, Remo; Rampinelli, Vittorio; Nicolai, Piero.

In: Oral Oncology, Vol. 65, 01.02.2017, p. 102-113.

Research output: Contribution to journalArticle

Lombardi, D, McGurk, M, Vander Poorten, V, Guzzo, M, Accorona, R, Rampinelli, V & Nicolai, P 2017, 'Surgical treatment of salivary malignant tumors.', Oral Oncology, vol. 65, pp. 102-113. https://doi.org/10.1016/j.oraloncology.2016.12.007
Lombardi D, McGurk M, Vander Poorten V, Guzzo M, Accorona R, Rampinelli V et al. Surgical treatment of salivary malignant tumors. Oral Oncology. 2017 Feb 1;65:102-113. https://doi.org/10.1016/j.oraloncology.2016.12.007
Lombardi, Davide ; McGurk, Marc ; Vander Poorten, Vincent ; Guzzo, Marco ; Accorona, Remo ; Rampinelli, Vittorio ; Nicolai, Piero. / Surgical treatment of salivary malignant tumors. In: Oral Oncology. 2017 ; Vol. 65. pp. 102-113.
@article{2cf7e7d5e1af4ba895d594bb6900af71,
title = "Surgical treatment of salivary malignant tumors.",
abstract = "Salivary gland malignant tumors (SGMT) are of key interest for head and neck surgeons since surgery with adjuvant radiotherapy is considered the treatment of choice in most of the cases. Some factors, namely rarity, high histologic heterogeneity, and possible occurrence in all the head and neck subsites, contribute to make this topic very controversial; some unclear aspects pertain surgical treatment. When dealing with major salivary gland malignant tumors (MaSGMT), the most debated issues remain the extent of surgery and management of facial nerve. In minor salivary gland malignant tumors (MiSGMT), conversely, surgical planning is influenced by the specific pattern of growth of the different neoplasms as well as the site of origin of the lesion. Finally, two additional issues, the treatment of the neck (therapeutic or elective) and reconstructive strategy after ablative surgery, are of pivotal importance in management of both MaSGMT and MiSGMT. In this review, we discuss the most relevant and controversial issues concerning surgery of SGMT.",
keywords = "Malignant tumor, Minor salivary gland, Neck, Parotid, Sublingual gland, Submandibular gland, Surgery",
author = "Davide Lombardi and Marc McGurk and {Vander Poorten}, Vincent and Marco Guzzo and Remo Accorona and Vittorio Rampinelli and Piero Nicolai",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.oraloncology.2016.12.007",
language = "Non definita",
volume = "65",
pages = "102--113",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Surgical treatment of salivary malignant tumors.

AU - Lombardi, Davide

AU - McGurk, Marc

AU - Vander Poorten, Vincent

AU - Guzzo, Marco

AU - Accorona, Remo

AU - Rampinelli, Vittorio

AU - Nicolai, Piero

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Salivary gland malignant tumors (SGMT) are of key interest for head and neck surgeons since surgery with adjuvant radiotherapy is considered the treatment of choice in most of the cases. Some factors, namely rarity, high histologic heterogeneity, and possible occurrence in all the head and neck subsites, contribute to make this topic very controversial; some unclear aspects pertain surgical treatment. When dealing with major salivary gland malignant tumors (MaSGMT), the most debated issues remain the extent of surgery and management of facial nerve. In minor salivary gland malignant tumors (MiSGMT), conversely, surgical planning is influenced by the specific pattern of growth of the different neoplasms as well as the site of origin of the lesion. Finally, two additional issues, the treatment of the neck (therapeutic or elective) and reconstructive strategy after ablative surgery, are of pivotal importance in management of both MaSGMT and MiSGMT. In this review, we discuss the most relevant and controversial issues concerning surgery of SGMT.

AB - Salivary gland malignant tumors (SGMT) are of key interest for head and neck surgeons since surgery with adjuvant radiotherapy is considered the treatment of choice in most of the cases. Some factors, namely rarity, high histologic heterogeneity, and possible occurrence in all the head and neck subsites, contribute to make this topic very controversial; some unclear aspects pertain surgical treatment. When dealing with major salivary gland malignant tumors (MaSGMT), the most debated issues remain the extent of surgery and management of facial nerve. In minor salivary gland malignant tumors (MiSGMT), conversely, surgical planning is influenced by the specific pattern of growth of the different neoplasms as well as the site of origin of the lesion. Finally, two additional issues, the treatment of the neck (therapeutic or elective) and reconstructive strategy after ablative surgery, are of pivotal importance in management of both MaSGMT and MiSGMT. In this review, we discuss the most relevant and controversial issues concerning surgery of SGMT.

KW - Malignant tumor, Minor salivary gland, Neck, Parotid, Sublingual gland, Submandibular gland, Surgery

U2 - 10.1016/j.oraloncology.2016.12.007

DO - 10.1016/j.oraloncology.2016.12.007

M3 - Articolo

VL - 65

SP - 102

EP - 113

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

ER -